Adc Therapeutics Sa

Penny Stocks Biotech Stocks Healthcare Stocks

$1.05

-0.01 (-0.94%)

As of Sep 20, 10:26 PM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 8 67%

Hold 3 25%

Sell 1 8%

Price Target

Analyst Price Target +1,763.8% upside

Low Target $11.03

Average Target $19.57

High Target $23.80

Current Price $1.05

Current
$1.05

Target
$19.57

$11.03 $19.57 avg $23.80

Scenario Analysis

Bear Case

$11.03

950.5%

Low target

Base Case

$19.57

+1,763.8%

Avg target

Bull Case

$23.80

+2,166.7%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$4.98

-78.9% from high

52-Week Low

$0.78

+34.7% from low

Target vs 52W High

$19.57

+293.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.9%
AMGN Amgen Inc	Hold	43	47%	$190.87	-53.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-14.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-18.1%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-63.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.8%